162 related articles for article (PubMed ID: 6986570)
1. Activation of the classic complement pathway in patients with the C3 nephritic factor.
McLean RH; Siegel NJ; Kashgarian M
Nephron; 1980; 25(2):57-64. PubMed ID: 6986570
[TBL] [Abstract][Full Text] [Related]
2. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
McLean RH; Nilson SH
Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
[No Abstract] [Full Text] [Related]
3. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
4. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
5. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
Power DA; Ng YC; Simpson JG
Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
[TBL] [Abstract][Full Text] [Related]
6. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
De Vecchi A; Montagnino G; Scalia P; Tarantino A
Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
[No Abstract] [Full Text] [Related]
7. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
8. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
Yamada A; Ohi H; Okano K; Watanabe S; Seki M; Hatano M; Koitabashi Y
J Clin Lab Immunol; 1988 Sep; 27(1):35-7. PubMed ID: 3251045
[TBL] [Abstract][Full Text] [Related]
9. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
Habib R; Lévy M; Gubler MC; Broyer M; Habib M
Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
[TBL] [Abstract][Full Text] [Related]
10. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
11. Mesangiocapillary glomerulonephritis with dense "deposits" in the basement membranes of the kidney.
Vargas R; Thomson KJ; Wilson D; Cameron JS; Turner DR; Gill D; Chantler C; Ogg CS
Clin Nephrol; 1976 Feb; 5(2):73-82. PubMed ID: 767025
[TBL] [Abstract][Full Text] [Related]
12. Herpes gestationis associated with the C3 nephritic factor.
Grimwood R; Arroyave CM; Weston WL; Aeling JL
Arch Dermatol; 1980 Sep; 116(9):1045-7. PubMed ID: 6998378
[TBL] [Abstract][Full Text] [Related]
13. C3 nephritic factor and mesangiocapillary glomerulonephritis.
Williams DG
Pediatr Nephrol; 1997 Feb; 11(1):96-8. PubMed ID: 9035182
[TBL] [Abstract][Full Text] [Related]
14. Test for C3 nephritic factor activity by immunofixation electrophoresis.
Koch FJ; Jenis EH; Valeski JE
Am J Clin Pathol; 1981 Jul; 76(1):63-7. PubMed ID: 6789671
[TBL] [Abstract][Full Text] [Related]
15. Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.
Mampaso F; Leyva-Cobián F; Martínez-Montero JC; Gonzalo A; Bellas C; Moneo I; Junquera E
Clin Nephrol; 1983 Feb; 19(2):92-8. PubMed ID: 6188567
[TBL] [Abstract][Full Text] [Related]
16. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.
Bennett WM; Bardana EJ; Wuepper K; Houghton D; Border WA; Götze O; Schreiber R
Am J Med; 1977 May; 62(5):757-60. PubMed ID: 860726
[TBL] [Abstract][Full Text] [Related]
17. Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.
Levy Y; George J; Yona E; Shoenfeld Y
Immunol Res; 1998 Aug; 18(1):55-60. PubMed ID: 9724849
[TBL] [Abstract][Full Text] [Related]
18. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
[No Abstract] [Full Text] [Related]
19. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
[TBL] [Abstract][Full Text] [Related]
20. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M; Balow JE; Tsokos GC
J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
